Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Thiohexam is a rubber cure accelerator. It is also a known allergen and dermatological sensitizer. Sensitivity to Thiohexam may be identified with a clinical patch test.
- Primary indication
- Thiohexam is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.Curator reviewed
- Formula / weight
- C13H16N2S2 · 264.41 g/mol (avg)
- First approval
- United States, 2012
- Also known as
- Cyclohexyl benzothiazolesulfenamide
Resolves to
Clinical / RWD
Structure
InChIKey
DEQZTKGFXNUBJL-UHFFFAOYSA-NSMILESC1CCC(CC1)NSC1=NC2=CC=CC=C2S1What you can answer from here — as of April 02, 2025
Which companies are running trials of Thiohexam, in which indications and phases, and which of those programs are still active?